The IMPACT of Molecular Grading of Gliomas on Contemporary Clinical Practice
- PMID: 32698972
- DOI: 10.1016/j.ijrobp.2020.05.043
The IMPACT of Molecular Grading of Gliomas on Contemporary Clinical Practice
Comment on
-
Announcing cIMPACT-NOW: the Consortium to Inform Molecular and Practical Approaches to CNS Tumor Taxonomy.Acta Neuropathol. 2017 Jan;133(1):1-3. doi: 10.1007/s00401-016-1646-x. Acta Neuropathol. 2017. PMID: 27909809 No abstract available.
-
cIMPACT-NOW update 3: recommended diagnostic criteria for "Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV".Acta Neuropathol. 2018 Nov;136(5):805-810. doi: 10.1007/s00401-018-1913-0. Epub 2018 Sep 26. Acta Neuropathol. 2018. PMID: 30259105 Free PMC article. No abstract available.
-
cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas.Acta Neuropathol. 2020 Mar;139(3):603-608. doi: 10.1007/s00401-020-02127-9. Epub 2020 Jan 29. Acta Neuropathol. 2020. PMID: 31996992 Free PMC article. No abstract available.
-
cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and grading.Brain Pathol. 2020 Jul;30(4):844-856. doi: 10.1111/bpa.12832. Epub 2020 Apr 19. Brain Pathol. 2020. PMID: 32307792 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
